Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL

Enrollment

280

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 28, 2010

Study Completion Date

December 31, 2010

Conditions

Allergic Rhinitis

Interventions

DRUG

Noex

The patients shall use the Noex drug only once a day (one application in each nostril) during the 12 weeks of treatment

DRUG

Budecort Aqua

The patients shall use the Budecort Aqua drug only once a day (one application in each nostril) during the 12 weeks of treatment.

Trial Locations (1)

IMA Brasil - Instituto de Pesquisa Clínica e Medicina Avançada, São Paulo